Aspire Biopharma Holdings (ASBP) Treasury Shares (2022 - 2024)
Aspire Biopharma Holdings (ASBP) posted quarterly Treasury Shares of $577644.0 for Q4 2024, down 67.98% year-over-year from $1.8 million in Q1 2024, and little changed quarter-over-quarter from $577644.0 in Q3 2024.
Aspire Biopharma Holdings (ASBP) Treasury Shares (2022 - 2024) Analysis & Trends
Aspire Biopharma Holdings (ASBP) has reported Treasury Shares for 3 consecutive years, with $577644.0 the latest figure, recorded in Q4 2024.
- In Q4 2024, Treasury Shares fell 67.98% year-over-year to $577644.0; the TTM figure through Dec 2024 stood at $577644.0 (down 67.98% YoY), while the FY2024 annual figure was $577644.0, down 67.98% from the prior year.
- Treasury Shares was little changed at $577644.0 in Q4 2024 per ASBP's latest filing, from $577644.0 in the prior quarter.
- Across five years, Treasury Shares topped out at $28.8 million in Q4 2022 and bottomed at $577644.0 in Q2 2024.
- Historically, Treasury Shares has averaged $7.4 million across 3 years, with a median of $1.8 million in 2023.
- Annual changes were most pronounced in 2023 — Treasury Shares tumbled 93.73% — and 2024, when it sank 67.98%.
- Aspire Biopharma Holdings' Treasury Shares stood at $28.8 million in 2022, then sank by 93.73% to $1.8 million in 2023, then tumbled by 67.98% to $577644.0 in 2024.
- Business Quant data shows ASBP's Treasury Shares at $577644.0 in Q4 2024, $577644.0 in Q3 2024, and $577644.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 8.96 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 2.72 Mn |
| 10 | Aspire Biopharma Holdings | 8.30 Mn | -3.86 Mn | -30,086.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 577,644.00 |
| Dec 31, 2024 | 577,644.00 |
| Sep 30, 2024 | 577,644.00 |
| Sep 30, 2024 | 577,644.00 |
| Jun 30, 2024 | 577,644.00 |
| Jun 30, 2024 | 577,644.00 |
| Mar 31, 2024 | 1.80 Mn |
| Mar 31, 2024 | 1.80 Mn |
| Dec 31, 2023 | 1.80 Mn |
| Dec 31, 2023 | 1.80 Mn |
| Sep 30, 2023 | 1.80 Mn |
| Sep 30, 2023 | 1.80 Mn |
| Jun 30, 2023 | 1.80 Mn |
| Jun 30, 2023 | 1.80 Mn |
| Mar 31, 2023 | 28.75 Mn |
| Mar 31, 2023 | 28.75 Mn |
| Dec 31, 2022 | 28.75 Mn |
| Dec 31, 2022 | 28.75 Mn |